FEATURED EDITORIAL
Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely
Department of Cardiology, Castle Hill Hospital, Hull Royal Infirmary and University of Hull, Kingston-upon-Hull, UK
Correspondence to:
Professor John G F Cleland, Department of Cardiology, University of Hull, Castle Hill Hospital, Kingston-upon-Hull, HU16 5JQ, UK; j.g.cleland@hull.ac.uk
| The first 150 words of the full text of this article appear below. |
Should patients with heart failure who require an implantable cardiac defibrillator (ICD) get a device capable of delivering cardiac resynchronisation therapy (CRT-D) routinely? For those that like to read the conclusions first, the answer is "yes". It is difficult to justify implanting only a defibrillator in anyone who has heart failure and an indication for an ICD. Most of these patients should get a CRT-D device.
This conclusion might seem odd at first but the arguments are quite straightforward. National Institute for Health and Clinical Excellence (NICE) guidelines1 suggest that patients with heart failure as a result of ischaemic heart disease (IHD) should get an ICD if their left ventricular ejection fraction (LVEF) is <35% and they also have non-sustained ventricular tachycardia (NSVT) on ambulatory electrocardiographic monitoring and inducible ventricular tachycardia (VT) on electrophysiological monitoring, provided that the patient is not in end-stage heart failure and is not within one
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Scott, P. A., Turner, N. G., Chungh, A., Morgan, J. M., Roberts, P. R.
(2009). Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace
11: 1048-1051
[Abstract] [Full Text] -
Cleland, J. G.F., Coletta, A. P., Clark, A. L., Cullington, D.
(2009). Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA. Eur J Heart Fail
11: 622-630
[Abstract] [Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Drugs: cardiovascular system
-
Epidemiology
-
Acute coronary syndromes
-
Interventional cardiology
- Pacing and electrophysiology
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
